Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0.964. It has been cited 21 times, with 15 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0.500
From 14 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 15 citers.
National Institutes of Health
Grant: R00CA215604
National Institutes of Health
Grant: R01CA240589
National Institutes of Health
Grant: DP2CA261453
National Institutes of Health
Grant: TL1TR003106
American Cancer Society
Grant: RSG-18-006-06-CCE
UAB O’Neal Comprehensive Cancer Center
Grant: P30CA013148
Howard Hughes Medical Institute
Grant: Gilliam Award
National Institutes of Health
Grant: 5R01CA240589-04
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging
National Institutes of Health
Grant: 2P30CA013148-34
TISSUE PROCUREMENT
National Institutes of Health
Grant: 4R00CA215604-03
Quantitative PET Imaging for Oncologic Immune Response Prediction
National Institutes of Health
Grant: 1DP2CA261453-01
Site-Specific Immune Cell Activation Detection for Improving Individualized Cancer Immunotherapy
National Institutes of Health
Grant: 1TL1TR003106-01
NRSA Training Core
FWCI
1.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals